Albuterol inhaler for allergies
Pro Research Analysisby 
Searched over 200M research papers
Albuterol Inhaler for Allergies: Effects on Asthmatic Responses
Introduction to Albuterol and Allergies
Albuterol, a commonly used beta(2)-agonist, is often prescribed for asthma management. However, its effects on allergen-induced asthmatic responses, particularly in allergic individuals, have been a subject of research. This article synthesizes findings from recent studies to understand how regular use of albuterol impacts allergen-induced asthmatic responses.
Impact on Early and Late Asthmatic Responses
Early Asthmatic Response (EAR)
Research indicates that inhaled albuterol can inhibit the early asthmatic response (EAR) when administered immediately before allergen exposure. This inhibition is beneficial as it helps in reducing the immediate symptoms triggered by allergens.
Late Asthmatic Response (LAR)
Contrary to its effects on EAR, regular use of albuterol has been shown to increase the late asthmatic response (LAR). Studies have demonstrated that a one-week treatment with albuterol significantly enhances the LAR, as evidenced by a greater fall in forced expiratory volume in 1 second (FEV1) compared to placebo. This suggests that while albuterol may provide short-term relief, its prolonged use could exacerbate late-phase allergic reactions.
Inflammatory Cell Response
Eosinophils and Sputum Analysis
Regular albuterol use has been associated with an increase in inflammatory cells, particularly eosinophils, in the airways. One study found that albuterol treatment significantly increased the number of sputum eosinophils and eosinophil cationic protein (ECP) levels at 7 hours post-allergen exposure, although these levels were not significantly different at 24 hours. This indicates that albuterol may enhance eosinophil influx into the airways, contributing to increased airway inflammation during the late response phase.
Blood Eosinophils and Airway Responsiveness
In addition to sputum eosinophils, regular albuterol use also increased blood eosinophil numbers and airway responsiveness to methacholine, a marker of airway hyperreactivity . This heightened responsiveness further underscores the potential for increased airway inflammation with regular albuterol use in allergic individuals.
Conclusion
While albuterol is effective in managing the early symptoms of allergen-induced asthma, its regular use may lead to increased late asthmatic responses and heightened airway inflammation. This is characterized by an increase in eosinophils and other inflammatory markers in the airways. Therefore, it is crucial for clinicians to consider these potential effects when prescribing albuterol for long-term use in allergic asthmatic patients. Further research is needed to explore alternative management strategies that mitigate these adverse effects while providing effective asthma control.
Sources and full results
Most relevant research papers on this topic